Membrane-potential-dependent inhibition of platelet adhesion to endothelial cells by epoxyeicosatrienoic acids

Arterioscler Thromb Vasc Biol. 2004 Mar;24(3):595-600. doi: 10.1161/01.ATV.0000116219.09040.8c. Epub 2004 Jan 8.

Abstract

Objective: Epoxyeicosatrienoic acids (EETs) are potent vasodilators produced by endothelial cells. In many vessels, they are an endothelium-derived hyperpolarizing factor (EDHF). However, it is unknown whether they act as an EDHF on platelets and whether this has functional consequences.

Methods and results: Flow cytometric measurement of platelet membrane potential using the fluorescent dye DiBac4 showed a resting potential of -58+/-9 mV. Different EET regioisomers hyperpolarized platelets down to -69+/-2 mV, which was prevented by the non-specific potassium channel inhibitor charybdotoxin and by use of a blocker of calcium-activated potassium channels of large conductance (BK(Ca) channels), iberiotoxin. EETs inhibited platelet adhesion to endothelial cells under static and flow conditions. Exposure to EETs inhibited platelet P-selectin expression in response to ADP. Stable overexpression of cytochrome P450 2C9 in EA.hy926 cells (EA.hy2C9 cells) resulted in release of EETs and a factor that hyperpolarized platelets and inhibited their adhesion to endothelial cells. These effects were again inhibited by charybdotoxin and iberiotoxin.

Conclusions: EETs hyperpolarize platelets and inactivate them by inhibiting adhesion molecule expression and platelet adhesion to cultured endothelial cells in a membrane potential-dependent manner. They act as an EDHF on platelets and might be important mediators of the anti-adhesive properties of vascular endothelium.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 8,11,14-Eicosatrienoic Acid / analogs & derivatives*
  • 8,11,14-Eicosatrienoic Acid / pharmacology*
  • Apamin / pharmacology
  • Aryl Hydrocarbon Hydroxylases / genetics
  • Aryl Hydrocarbon Hydroxylases / metabolism
  • Biological Factors / physiology
  • Blood Platelets / physiology*
  • Cells, Cultured / cytology
  • Cells, Cultured / enzymology
  • Charybdotoxin / pharmacology
  • Cytochrome P-450 CYP2C9
  • Endothelial Cells / cytology*
  • Endothelial Cells / enzymology
  • Endothelium, Vascular / cytology*
  • Humans
  • Hydroxyeicosatetraenoic Acids / pharmacology
  • Ion Channels / drug effects
  • Membrane Potentials / drug effects
  • Membrane Potentials / physiology*
  • Peptides / pharmacology
  • Platelet Adhesiveness / drug effects*
  • Platelet Adhesiveness / physiology
  • Platelet Aggregation / drug effects
  • Platelet Aggregation / physiology
  • Potassium Channels / drug effects
  • Potassium Channels / physiology
  • Recombinant Fusion Proteins / metabolism
  • Transfection
  • Umbilical Veins

Substances

  • 14,15-dihydroxyeicosatrienoic acid
  • Biological Factors
  • Hydroxyeicosatetraenoic Acids
  • Ion Channels
  • Peptides
  • Potassium Channels
  • Recombinant Fusion Proteins
  • endothelium-dependent hyperpolarization factor
  • Charybdotoxin
  • Apamin
  • 11,12-epoxy-5,8,14-eicosatrienoic acid
  • iberiotoxin
  • 5,6-epoxy-8,11,14-eicosatrienoic acid
  • 8,9-epoxyeicosatrienoic acid
  • 14,15-epoxy-5,8,11-eicosatrienoic acid
  • CYP2C9 protein, human
  • Cytochrome P-450 CYP2C9
  • Aryl Hydrocarbon Hydroxylases
  • 8,11,14-Eicosatrienoic Acid